Option Care Health, Inc. (NASDAQ:OPCH) Receives $30.54 Average Price Target from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has been given an average rating of “Moderate Buy” by the fourteen ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $30.5385.

OPCH has been the topic of a number of recent analyst reports. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target on the stock. in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a research note on Friday, May 1st. Weiss Ratings cut Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Truist Financial set a $30.00 target price on Option Care Health in a research note on Friday, May 1st. Finally, Stephens set a $30.00 price target on Option Care Health in a report on Friday, May 1st.

Insider Transactions at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Timothy P. Sullivan purchased 24,154 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was acquired at an average cost of $20.69 per share, with a total value of $499,746.26. Following the purchase, the director directly owned 73,383 shares of the company’s stock, valued at $1,518,294.27. This trade represents a 49.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders have acquired 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. V Square Quantitative Management LLC purchased a new position in Option Care Health during the 4th quarter valued at about $25,000. Advisory Services Network LLC purchased a new stake in Option Care Health in the third quarter worth about $35,000. McIlrath & Eck LLC purchased a new stake in Option Care Health in the second quarter worth about $37,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health during the third quarter valued at approximately $38,000. Finally, Quarry LP increased its stake in shares of Option Care Health by 502.7% during the third quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after purchasing an additional 1,292 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $21.90 on Friday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. Option Care Health has a 52-week low of $18.01 and a 52-week high of $36.80. The stock has a market capitalization of $3.44 billion, a price-to-earnings ratio of 16.98, a P/E/G ratio of 1.22 and a beta of 0.65. The company’s 50 day moving average price is $21.67 and its 200-day moving average price is $28.26.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the previous year, the firm earned $0.40 earnings per share. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts forecast that Option Care Health will post 1.64 EPS for the current year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.